Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.
Saved in:
| Title: | Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study. |
|---|---|
| Authors: | Kortuem KU; University Eye Hospital Ulm, Germany and Augenarztpraxis Dres. Kortüm, Ludwigsburg, Germany, Ulm, Germany., Zarranz-Ventura J; University of Barcelona, Hospital Clinic de Barcelona, Barcelona, Spain., Bandello F; Department of Ophthalmology, University Vita Salute Hospital San Raffaele, Milano, Italy., Duval R; Ophthalmology, University of Montreal, Montreal, Quebec, Canada., O'Toole L; Department of Ophthalmology, Bon Secours Hospital Dublin, Dublin, Leinster, Ireland., De Zanet S; Ikerian AG, Bern, Switzerland., Blair JPM; Research, Ikerian AG, Bern, Switzerland., Seaman J; Novartis Parmaceuticals, Mansfield, Texas, USA., Zvolanek M; Novartis Pharma GmbH, Nürnberg, Bayern, Germany., Jaeger K; Novartis Pharma GmbH, Nürnberg, Bayern, Germany., Gmeiner B; Novartis Pharma GmbH, Nürnberg, Bayern, Germany benjamingmeiner@googlemail.com.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Nordrhein-Westfalen, Germany. |
| Source: | The British journal of ophthalmology [Br J Ophthalmol] 2026 May 04. Date of Electronic Publication: 2026 May 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2079 (Electronic) Linking ISSN: 00071161 NLM ISO Abbreviation: Br J Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42082322 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kortuem+KU%22">Kortuem KU</searchLink>; University Eye Hospital Ulm, Germany and Augenarztpraxis Dres. Kortüm, Ludwigsburg, Germany, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Zarranz-Ventura+J%22">Zarranz-Ventura J</searchLink>; University of Barcelona, Hospital Clinic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bandello+F%22">Bandello F</searchLink>; Department of Ophthalmology, University Vita Salute Hospital San Raffaele, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Duval+R%22">Duval R</searchLink>; Ophthalmology, University of Montreal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22O'Toole+L%22">O'Toole L</searchLink>; Department of Ophthalmology, Bon Secours Hospital Dublin, Dublin, Leinster, Ireland.<br /><searchLink fieldCode="AU" term="%22De+Zanet+S%22">De Zanet S</searchLink>; Ikerian AG, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Blair+JPM%22">Blair JPM</searchLink>; Research, Ikerian AG, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Seaman+J%22">Seaman J</searchLink>; Novartis Parmaceuticals, Mansfield, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zvolanek+M%22">Zvolanek M</searchLink>; Novartis Pharma GmbH, Nürnberg, Bayern, Germany.<br /><searchLink fieldCode="AU" term="%22Jaeger+K%22">Jaeger K</searchLink>; Novartis Pharma GmbH, Nürnberg, Bayern, Germany.<br /><searchLink fieldCode="AU" term="%22Gmeiner+B%22">Gmeiner B</searchLink>; Novartis Pharma GmbH, Nürnberg, Bayern, Germany benjamingmeiner@googlemail.com.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Holz+FG%22">Holz FG</searchLink>; Department of Ophthalmology, University of Bonn, Bonn, Nordrhein-Westfalen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220421041%22">The British journal of ophthalmology</searchLink> [Br J Ophthalmol] 2026 May 04. <i>Date of Electronic Publication: </i>2026 May 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Pub%2E+Group%22">BMJ Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0421041 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-2079 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071161%22">00071161 </searchLink><i>NLM ISO Abbreviation: </i>Br J Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42082322 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bjo-2024-327060 Languages: – Code: eng Text: English Titles: – TitleFull: Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kortuem KU – PersonEntity: Name: NameFull: Zarranz-Ventura J – PersonEntity: Name: NameFull: Bandello F – PersonEntity: Name: NameFull: Duval R – PersonEntity: Name: NameFull: O'Toole L – PersonEntity: Name: NameFull: De Zanet S – PersonEntity: Name: NameFull: Blair JPM – PersonEntity: Name: NameFull: Seaman J – PersonEntity: Name: NameFull: Zvolanek M – PersonEntity: Name: NameFull: Jaeger K – PersonEntity: Name: NameFull: Gmeiner B – PersonEntity: Name: NameFull: Holz FG IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 05 Text: 2026 May 04 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1468-2079 Titles: – TitleFull: The British journal of ophthalmology Type: main |
| ResultId | 1 |